The effect of lexipafant on bacterial translocation in acute necrotizing pancreatitis in rats

Qiang Liu, Goldie Djuricin, Heather Rossi, Kelly Bewsey, Catherine Nathan, Paolo Gattuso, Robert A. Weinstein, Richard A. Prinz

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Bacterial translocation (BT) from the gastrointestinal tract to mesenteric lymph nodes (MLNs) and other extra intestinal organs is an important source of infection in acute pancreatitis (AP). Lexipafant (BB- 882) is a potent platelet-activating factor receptor antagonist that has an anti-inflammatory effect. To examine whether BB-882 could affect BT in acute necrotizing pancreatitis, 48 male Sprague Dawley rats (250-350 g) were studied. AP was induced in Group I and Group II by pressure injection of 3% taurocholate and trypsin into the common biliopancreatic duct (1 mL/kg of body weight). Group I rats received BB-882 (10 mg/kg, ip qd) and Group II rats received a similar volume of normal saline as a placebo postoperatively for 2 days. Group III and Group IV received BB-882 and placebo, respectively, after an exploratory laparotomy. At 48 hours postoperatively, blood was drawn for culture, serum amylase, and tumor necrosis factor (TNF)-α determinations. Specimens from MLNs, spleen, liver, pancreas, and cecum were harvested for culture of Gram-positive, Gram-negative, and anaerobic bacteria. Quantitative cecal cultures of Gram-positive, Gram-negative, and anaerobic bacteria were obtained. A point scoring system for five histological features that include interstitial edema, inflammatory cellular infiltration, fat necrosis, parenchymal necrosis, and hemorrhage was used to evaluate the severity of pancreatitis. There was no difference in serum amylase levels (2415 ± 127 IU/L versus 2476 ± 170 IU/L), serum TNF-α levels (7820 ± 1396 pg/mL versus 7318 ± 681 pg/mL), and the mean pancreatic histology score (5.9 ± 1.2 versus 6.5 ± 1.1) between Group I and Group II, respectively (P > 0.05). Seven of 12 Group I rats had BT to MLNs, compared with 11 of 12 rats in Group II (P > 0.05). Five of 12 Group I rats had BT to distant sites such as pancreas, spleen, liver, and/or blood, compared with 11 of 12 rats in Group II (P < 0.05). BB-882 treatment decreases bacterial spread to distant sites, but does not reduce serum amylase levels and serum TNF-α levels or ameliorate pancreatic damage in rats with AP.

Original languageEnglish (US)
Pages (from-to)611-617
Number of pages7
JournalAmerican Surgeon
Volume65
Issue number7
StatePublished - Jul 1999
Externally publishedYes

Fingerprint

Acute Necrotizing Pancreatitis
Bacterial Translocation
Pancreatitis
Amylases
Gram-Negative Anaerobic Bacteria
Serum
Tumor Necrosis Factor-alpha
Lymph Nodes
Pancreas
Spleen
Placebos
Fat Necrosis
Taurocholic Acid
Cecum
Liver
lexipafant
Laparotomy
Trypsin
Sprague Dawley Rats
Gastrointestinal Tract

ASJC Scopus subject areas

  • Surgery

Cite this

Liu, Q., Djuricin, G., Rossi, H., Bewsey, K., Nathan, C., Gattuso, P., ... Prinz, R. A. (1999). The effect of lexipafant on bacterial translocation in acute necrotizing pancreatitis in rats. American Surgeon, 65(7), 611-617.

The effect of lexipafant on bacterial translocation in acute necrotizing pancreatitis in rats. / Liu, Qiang; Djuricin, Goldie; Rossi, Heather; Bewsey, Kelly; Nathan, Catherine; Gattuso, Paolo; Weinstein, Robert A.; Prinz, Richard A.

In: American Surgeon, Vol. 65, No. 7, 07.1999, p. 611-617.

Research output: Contribution to journalArticle

Liu, Q, Djuricin, G, Rossi, H, Bewsey, K, Nathan, C, Gattuso, P, Weinstein, RA & Prinz, RA 1999, 'The effect of lexipafant on bacterial translocation in acute necrotizing pancreatitis in rats', American Surgeon, vol. 65, no. 7, pp. 611-617.
Liu Q, Djuricin G, Rossi H, Bewsey K, Nathan C, Gattuso P et al. The effect of lexipafant on bacterial translocation in acute necrotizing pancreatitis in rats. American Surgeon. 1999 Jul;65(7):611-617.
Liu, Qiang ; Djuricin, Goldie ; Rossi, Heather ; Bewsey, Kelly ; Nathan, Catherine ; Gattuso, Paolo ; Weinstein, Robert A. ; Prinz, Richard A. / The effect of lexipafant on bacterial translocation in acute necrotizing pancreatitis in rats. In: American Surgeon. 1999 ; Vol. 65, No. 7. pp. 611-617.
@article{8871efe75c1c405db7aaf0328dc2d735,
title = "The effect of lexipafant on bacterial translocation in acute necrotizing pancreatitis in rats",
abstract = "Bacterial translocation (BT) from the gastrointestinal tract to mesenteric lymph nodes (MLNs) and other extra intestinal organs is an important source of infection in acute pancreatitis (AP). Lexipafant (BB- 882) is a potent platelet-activating factor receptor antagonist that has an anti-inflammatory effect. To examine whether BB-882 could affect BT in acute necrotizing pancreatitis, 48 male Sprague Dawley rats (250-350 g) were studied. AP was induced in Group I and Group II by pressure injection of 3{\%} taurocholate and trypsin into the common biliopancreatic duct (1 mL/kg of body weight). Group I rats received BB-882 (10 mg/kg, ip qd) and Group II rats received a similar volume of normal saline as a placebo postoperatively for 2 days. Group III and Group IV received BB-882 and placebo, respectively, after an exploratory laparotomy. At 48 hours postoperatively, blood was drawn for culture, serum amylase, and tumor necrosis factor (TNF)-α determinations. Specimens from MLNs, spleen, liver, pancreas, and cecum were harvested for culture of Gram-positive, Gram-negative, and anaerobic bacteria. Quantitative cecal cultures of Gram-positive, Gram-negative, and anaerobic bacteria were obtained. A point scoring system for five histological features that include interstitial edema, inflammatory cellular infiltration, fat necrosis, parenchymal necrosis, and hemorrhage was used to evaluate the severity of pancreatitis. There was no difference in serum amylase levels (2415 ± 127 IU/L versus 2476 ± 170 IU/L), serum TNF-α levels (7820 ± 1396 pg/mL versus 7318 ± 681 pg/mL), and the mean pancreatic histology score (5.9 ± 1.2 versus 6.5 ± 1.1) between Group I and Group II, respectively (P > 0.05). Seven of 12 Group I rats had BT to MLNs, compared with 11 of 12 rats in Group II (P > 0.05). Five of 12 Group I rats had BT to distant sites such as pancreas, spleen, liver, and/or blood, compared with 11 of 12 rats in Group II (P < 0.05). BB-882 treatment decreases bacterial spread to distant sites, but does not reduce serum amylase levels and serum TNF-α levels or ameliorate pancreatic damage in rats with AP.",
author = "Qiang Liu and Goldie Djuricin and Heather Rossi and Kelly Bewsey and Catherine Nathan and Paolo Gattuso and Weinstein, {Robert A.} and Prinz, {Richard A.}",
year = "1999",
month = "7",
language = "English (US)",
volume = "65",
pages = "611--617",
journal = "American Surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "7",

}

TY - JOUR

T1 - The effect of lexipafant on bacterial translocation in acute necrotizing pancreatitis in rats

AU - Liu, Qiang

AU - Djuricin, Goldie

AU - Rossi, Heather

AU - Bewsey, Kelly

AU - Nathan, Catherine

AU - Gattuso, Paolo

AU - Weinstein, Robert A.

AU - Prinz, Richard A.

PY - 1999/7

Y1 - 1999/7

N2 - Bacterial translocation (BT) from the gastrointestinal tract to mesenteric lymph nodes (MLNs) and other extra intestinal organs is an important source of infection in acute pancreatitis (AP). Lexipafant (BB- 882) is a potent platelet-activating factor receptor antagonist that has an anti-inflammatory effect. To examine whether BB-882 could affect BT in acute necrotizing pancreatitis, 48 male Sprague Dawley rats (250-350 g) were studied. AP was induced in Group I and Group II by pressure injection of 3% taurocholate and trypsin into the common biliopancreatic duct (1 mL/kg of body weight). Group I rats received BB-882 (10 mg/kg, ip qd) and Group II rats received a similar volume of normal saline as a placebo postoperatively for 2 days. Group III and Group IV received BB-882 and placebo, respectively, after an exploratory laparotomy. At 48 hours postoperatively, blood was drawn for culture, serum amylase, and tumor necrosis factor (TNF)-α determinations. Specimens from MLNs, spleen, liver, pancreas, and cecum were harvested for culture of Gram-positive, Gram-negative, and anaerobic bacteria. Quantitative cecal cultures of Gram-positive, Gram-negative, and anaerobic bacteria were obtained. A point scoring system for five histological features that include interstitial edema, inflammatory cellular infiltration, fat necrosis, parenchymal necrosis, and hemorrhage was used to evaluate the severity of pancreatitis. There was no difference in serum amylase levels (2415 ± 127 IU/L versus 2476 ± 170 IU/L), serum TNF-α levels (7820 ± 1396 pg/mL versus 7318 ± 681 pg/mL), and the mean pancreatic histology score (5.9 ± 1.2 versus 6.5 ± 1.1) between Group I and Group II, respectively (P > 0.05). Seven of 12 Group I rats had BT to MLNs, compared with 11 of 12 rats in Group II (P > 0.05). Five of 12 Group I rats had BT to distant sites such as pancreas, spleen, liver, and/or blood, compared with 11 of 12 rats in Group II (P < 0.05). BB-882 treatment decreases bacterial spread to distant sites, but does not reduce serum amylase levels and serum TNF-α levels or ameliorate pancreatic damage in rats with AP.

AB - Bacterial translocation (BT) from the gastrointestinal tract to mesenteric lymph nodes (MLNs) and other extra intestinal organs is an important source of infection in acute pancreatitis (AP). Lexipafant (BB- 882) is a potent platelet-activating factor receptor antagonist that has an anti-inflammatory effect. To examine whether BB-882 could affect BT in acute necrotizing pancreatitis, 48 male Sprague Dawley rats (250-350 g) were studied. AP was induced in Group I and Group II by pressure injection of 3% taurocholate and trypsin into the common biliopancreatic duct (1 mL/kg of body weight). Group I rats received BB-882 (10 mg/kg, ip qd) and Group II rats received a similar volume of normal saline as a placebo postoperatively for 2 days. Group III and Group IV received BB-882 and placebo, respectively, after an exploratory laparotomy. At 48 hours postoperatively, blood was drawn for culture, serum amylase, and tumor necrosis factor (TNF)-α determinations. Specimens from MLNs, spleen, liver, pancreas, and cecum were harvested for culture of Gram-positive, Gram-negative, and anaerobic bacteria. Quantitative cecal cultures of Gram-positive, Gram-negative, and anaerobic bacteria were obtained. A point scoring system for five histological features that include interstitial edema, inflammatory cellular infiltration, fat necrosis, parenchymal necrosis, and hemorrhage was used to evaluate the severity of pancreatitis. There was no difference in serum amylase levels (2415 ± 127 IU/L versus 2476 ± 170 IU/L), serum TNF-α levels (7820 ± 1396 pg/mL versus 7318 ± 681 pg/mL), and the mean pancreatic histology score (5.9 ± 1.2 versus 6.5 ± 1.1) between Group I and Group II, respectively (P > 0.05). Seven of 12 Group I rats had BT to MLNs, compared with 11 of 12 rats in Group II (P > 0.05). Five of 12 Group I rats had BT to distant sites such as pancreas, spleen, liver, and/or blood, compared with 11 of 12 rats in Group II (P < 0.05). BB-882 treatment decreases bacterial spread to distant sites, but does not reduce serum amylase levels and serum TNF-α levels or ameliorate pancreatic damage in rats with AP.

UR - http://www.scopus.com/inward/record.url?scp=0032994189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032994189&partnerID=8YFLogxK

M3 - Article

C2 - 10399968

AN - SCOPUS:0032994189

VL - 65

SP - 611

EP - 617

JO - American Surgeon

JF - American Surgeon

SN - 0003-1348

IS - 7

ER -